These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2995079)

  • 1. Involvement of different opioid receptor subtypes in electric shock-induced analgesia and motor suppression in the rat.
    Nabeshima T; Matsuno K; Kameyama T
    Eur J Pharmacol; 1985 Aug; 114(2):197-207. PubMed ID: 2995079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electric footshock-induced changes in behavior and opioid receptor function.
    Nabeshima T; Matsuno K; Kamei H; Noda Y; Kameyama T
    Pharmacol Biochem Behav; 1985 Nov; 23(5):769-75. PubMed ID: 3001781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned suppression and opioid kappa receptor in mice.
    Nabeshima T; Kamei H; Matsuno K; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):74-80. PubMed ID: 3012059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of different opioid systems to footshock-induced analgesia and motor suppression.
    Nabeshima T; Yamada K; Kameyama T
    Eur J Pharmacol; 1983 Sep; 92(3-4):199-205. PubMed ID: 6138260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different changes by acute electric footshock of opioid agonist and antagonist receptors in rat brain.
    Kameyama T; Nabeshima T; Matsuno K; Suzuki M
    Neurosci Lett; 1984 Aug; 49(3):307-12. PubMed ID: 6093006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid activity of lefetamine.
    De Montis MG; Devoto P; Bucarelli A; Tagliamonte A
    Pharmacol Res Commun; 1985 May; 17(5):471-8. PubMed ID: 2994123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effects of ethylketocyclazocine and morphine in rat and toad.
    Carr KD; Aleman DO; Holland MJ; Simon EJ
    Life Sci; 1984 Aug; 35(9):997-1003. PubMed ID: 6433131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ; Hazum E; Cuatrecasas P
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4469-73. PubMed ID: 6254028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of kappa-opioid receptor subtype from frog brain.
    Simon J; Benyhe S; Borsodi A; Szücs M; Wollemann M
    FEBS Lett; 1985 Apr; 183(2):395-7. PubMed ID: 2985433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.